India ENT Devices Market Report 2022 to 2030

India ENT Devices Market Analysis

$ 3999

India's ENT Devices Market is projected to grow from $420 Mn in 2022 to $820 Mn by 2030, registering a CAGR of 9% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. The domestic key players in the India ENT devices market include Phoenix Medical Systems, Surgitech Innovations, and Zephyr Surgicals.

ID: IN10INMD009 CATEGORY: Medical Devices GEOGRAPHY: India AUTHOR: Dr. Vishwa Modhia

Buy Now

India ENT Devices Market Analysis Summary

India's ENT Devices Market is projected to grow from $420 Mn in 2022 to $820 Mn by 2030, registering a CAGR of 9% during the forecast period of 2022-30.

India is a lower-middle-income, developing country located in Southern Asia bordering the Arabian Sea and the Bay of Bengal. India is well-known throughout the world for providing outstanding ENT care and treatments at significantly lower costs than Western countries. After Japan, China, and South Korea, India is the fourth-largest Asian medical device market and is among the top 20 medical device markets worldwide. One of the most critical issues confronting the ENT medical device sector is the complex regulatory environment. Policymakers in India will need to devise a strategy to lessen the country's reliance on medical device and technology imports. India's government spent 3 % of its GDP on healthcare in 2020.

India ENT Devices Market

Market Dynamics

Market Growth Drivers Analysis

The new Medical Device Policy is projected to assist the Medical Devices Sector grow from its current value of $11 Bn to $50 Bn by 2030. COVID-19 has pushed current digital healthcare trends in India, opening up new market opportunities for global MedTech AI and software companies. The Production Linked Incentive (PLI) plan promotes domestic medical device manufacture. The NMDP 2023 will supplement the existing PLI programmes. Many recent technological advances in ENT devices, such as 3D printing, robotics, and artificial intelligence, have occurred. Chinese companies are investing in these technologies to stay competitive. These aspects could boost India's ENT Devices Market.

Market restrains.

In India, there are severe standards that must be met. One of the most critical issues confronting the medical device sector is the complex regulatory environment. Manufacturers must manage inconsistencies in legislation that employ different standards and terminology, making it difficult to understand and comply with the requirements. In the Indian medical device market, the adoption of cutting-edge technology such as artificial intelligence, cloud computing, and robots is relatively restricted. These factors may deter new entrants into the India ENT Devices Market.

Competitive Landscape

Key Players

Zephyr Surgicals - Based in Mumbai, India, Zephyr Surgicals produces a range of ENT medical devices, including nasal splints, ear wicks, and sinus stents
Eon Meditech Pvt Ltd - Based in Ahmedabad, India, Eon Meditech produces a range of ENT medical devices, including ear specula, forceps, and microdebriders
Surgitech Innovations - Based in New Delhi, India, Surgitech Innovations produces a range of ENT medical devices, including laryngoscopes, endoscopes, and surgical instruments
Trivitron Healthcare - Based in Chennai, India, Trivitron Healthcare produces a range of medical devices, including ENT devices such as ear irrigation systems, audiometers, and hearing aids
Phoenix Medical Systems Pvt Ltd- Based in Chennai, India, Phoenix Medical Systems produces a range of medical devices, including ENT devices such as nasal splints, ear syringes, and endoscopes

Recent Notable Updates

April 2023: In India, there are severe standards that must be met. One of the most critical issues confronting the medical device sector is the complex regulatory environment. Manufacturers must manage inconsistencies in legislation that employ different standards and terminology, making it difficult to understand and comply with the requirements. In the Indian medical device market, the adoption of cutting-edge technology such as artificial intelligence, cloud computing, and robots is relatively restricted.

Healthcare Policies and Reimbursement Scenarios

Indian healthcare regulators at the Central Drugs Standard Control Organization (CDSCO) have issued substantial new risk-based classification lists for ENT and Medical Devices in India. All ENT Products now need to be registered in order to comply with the latest Medical Device Rules in India. In India, the regulation and reimbursement of ENT (Ear, Nose, and Throat) devices are overseen by various bodies, including the Central Drugs Standard Control Organization (CDSCO) and the National Health Authority (NHA).

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

ENT Device Market Segmentation

The ENT Device Market is segmented as mentioned below:

By Product Type (Revenue, USD Billion):

Diagnostic Devices
Surgical Devices
Hearing Aids
Hearing Implants
Co2 Lasers
Image-Guided Surgery Systems

By Diagnostic Devices (Revenue, USD Billion):

Endocsopes
Hearing Screening Devices

By Surgical Device (Revenue, USD Billion):

Powered Surgical Instruments
Radiofrequency (RF) Handpieces
Handheld Instruments
Balloon Sinus Dilation Devices
ENT Supplies
Ear Tubes
Voice Prosthesis Devices

By End Users (Revenue, USD Billion):

Hospitals and Ambulatory Settings
Home Use
ENT Clinics

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.